European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 3 , Pages 366-370 , September 2008

Efficacy of Polidocanol Foam versus Liquid in Sclerotherapy of the Great Saphenous Vein: A Multicentre Randomised Controlled Trial with a 2-year Follow-up

  • P. Ouvry

      Affiliations

    • Cabinet d'angiologie, 9 rue Jules Ferry, Dieppe, France
    • ,
  • F.-A. Allaert

      Affiliations

    • Department of Epidemiology, Biostatistics and Occupational Medicine, Mc Gill University, Montreal, Canada
    • ,
  • P. Desnos

      Affiliations

    • Cabinet de Médecine Vasculaire, 2 avenue Bagatelle, Caen, France
    • ,
  • C. Hamel-Desnos

      Affiliations

    • Centre Hospitalier Privé Saint Martin, 18 rue des Roquemonts, 14050 Caen, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 231 433434; fax: +33 231 433330.

Received 28 November 2007 ,Accepted 13 April 2008.

References 

  1. Mc Ausland S. The modern treatment of varicose veins. Med Press Circular. 1939;201:404–410
  2. Ree A. Etamolin foam in the treatment of varicose veins: a new method. Acta Derm Venereol. 1953;33:435–436
  3. Cabrera Garrido JR. Elargissement des limites de la sclérothérapie: nouveaux produits sclérosants. Phlébologie. 1997;50:181–188
  4. Monfreux A. Traitement sclérosant des troncs saphèniens et leurs collatérales de gros calibre par la méthode MUS. Phlébologie. 1997;50:351–353
  5. Tessari L. Nouvelle technique d'obtention de la scléro-mousse. Phlébologie. 2000;53(1):129
  6. Frullini A. New technique in producing sclerosing foam in a disposable syringe. Dermatol Surg. 2000;26(7):705–706
  7. Frullini A, Cavezzi A. Echosclérose par mousse de tétradécyl-sulfate de sodium et de polidocanol: deux années d'expérience. Phlébologie. 2000;53(4):431–435
  8. Cabrera J, Cabrera J, Garcia-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in micro-form foam: long term outcomes. Phlebology. 2000;15:19–23
  9. Bhowmick A, Harper D, Wright D, et al. Polidocanol microfoam sclerotherapy for long saphenous varicose veins. Phlebology. 2001;16:41–50
  10. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology. 2002;17:13–18
  11. Hamel-Desnos C, Desnos P. Nouveautés thérapeutiques dans la prise en charge de la maladie variqueuse: Echosclérothérapie et mousse. Phlébologie. 2003;56:41–48
  12. Schadeck M. Aktualler Stand der Sclerosierungtherapie von Varizen. Hautarzt. 2003;54:1065–1072
  13. Hamel-Desnos C, Desnos P, Wollman JC, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg. 2003;29:1170–1175
  14. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg. 2004;30:6–12
  15. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam UGS treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg. 2004;30:1386–1390
  16. Coleridge Smith P. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006;32:577–583
  17. Hamel-Desnos C, Desnos P. L'échosclérothérapie à la mousse en 2004 – Technique de la ponction-injection directe. Phlébologie. 2004;57(3):289–300
  18. Schadeck M, Allaert FA. Duplex scanning in the mechanism of the sclerotherapy: importance of the spasm. Phlebology. 1995;1(Suppl):574–576
  19. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg. 2004;30(5):718–722
  20. Rabe E, Schliephake D, Otto J. A phase III study of efficacy and safety of the treatment of varicose veins with standardized Polidocanol (Aethoxysklerol) foam – ESAF study. Phlebologie. 2006;4:A36
  21. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg. 2008;35:238–245
  22. Alos J, Carreno P, Lopez JA, Estadella B, Serra Prat M, MarinelIo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg. 2006;31:101–107
  23. Wright D, Gobin J-P, Bradbury AW, et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology. 2006;21(4):180–190
  24. Ceulen RP, Bullens-Goessens YI, et al. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg. 2007;33:276–281
  25. Myers K, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg. 2007;33:116–121
  26. Hamel-Desnos C, Ouvry P, Bénigni J-P, Boitelle G, Schadeck M, Desnos P, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up: “the 3/1 study”. Eur J Vasc Endovasc Surg. 2007;34:723–729
  27. Breu FX, Guggenbichler S, Wollmann JC. 2nd European consensus meeting on foam sclerotherapy 2006. Tegernsee, Germany: Vasa; 2008;S/713–29
  28. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94:925–936

PII: S1078-5884(08)00225-6

doi: 10.1016/j.ejvs.2008.04.010

European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 3 , Pages 366-370 , September 2008

Article Tools

* Image Usage & Resolution